The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia
(Q73795156)
scientific article published on 01 May 2000
scientific article published on 01 May 2000
Language:
other details
description | scientific article published on 01 May 2000 |
External Links
(P356) |
10.1016/S0301-472X(00)00142-9
|
(P698) |
10812245
|